DK1112067T3 - Anvendelse af acetylcholinesteraseinhibitorer til fremstilling af farmaceutiske præparater til behandling af funktionelle og/eller organiske smertesyndromer - Google Patents
Anvendelse af acetylcholinesteraseinhibitorer til fremstilling af farmaceutiske præparater til behandling af funktionelle og/eller organiske smertesyndromerInfo
- Publication number
- DK1112067T3 DK1112067T3 DK99946150T DK99946150T DK1112067T3 DK 1112067 T3 DK1112067 T3 DK 1112067T3 DK 99946150 T DK99946150 T DK 99946150T DK 99946150 T DK99946150 T DK 99946150T DK 1112067 T3 DK1112067 T3 DK 1112067T3
- Authority
- DK
- Denmark
- Prior art keywords
- treatment
- functional
- preparation
- pain syndromes
- pharmaceutical compositions
- Prior art date
Links
- 239000000544 cholinesterase inhibitor Substances 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 208000011580 syndromic disease Diseases 0.000 title 1
- ADEBPBSSDYVVLD-UHFFFAOYSA-N donepezil Chemical compound O=C1C=2C=C(OC)C(OC)=CC=2CC1CC(CC1)CCN1CC1=CC=CC=C1 ADEBPBSSDYVVLD-UHFFFAOYSA-N 0.000 abstract 2
- 206010064012 Central pain syndrome Diseases 0.000 abstract 1
- 208000001640 Fibromyalgia Diseases 0.000 abstract 1
- 208000019695 Migraine disease Diseases 0.000 abstract 1
- 208000004983 Phantom Limb Diseases 0.000 abstract 1
- 238000002266 amputation Methods 0.000 abstract 1
- 230000001363 autoimmune Effects 0.000 abstract 1
- 230000002638 denervation Effects 0.000 abstract 1
- 229960003530 donepezil Drugs 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 206010027599 migraine Diseases 0.000 abstract 1
- 230000000472 traumatic effect Effects 0.000 abstract 1
- 230000001173 tumoral effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/325—Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Neurosurgery (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pain & Pain Management (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT1998FI000208A IT1304904B1 (it) | 1998-09-11 | 1998-09-11 | Derivati anticolinesterasici per il trattamento delle sindromidolorose funzionali e/o organiche |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1112067T3 true DK1112067T3 (da) | 2006-09-04 |
Family
ID=11352669
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK99946150T DK1112067T3 (da) | 1998-09-11 | 1999-09-09 | Anvendelse af acetylcholinesteraseinhibitorer til fremstilling af farmaceutiske præparater til behandling af funktionelle og/eller organiske smertesyndromer |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US6608088B1 (de) |
| EP (1) | EP1112067B1 (de) |
| JP (1) | JP3984787B2 (de) |
| AT (1) | ATE327740T1 (de) |
| AU (1) | AU5861799A (de) |
| CY (1) | CY1105125T1 (de) |
| DE (1) | DE69931640T2 (de) |
| DK (1) | DK1112067T3 (de) |
| ES (1) | ES2265691T3 (de) |
| IT (1) | IT1304904B1 (de) |
| PT (1) | PT1112067E (de) |
| WO (1) | WO2000015205A2 (de) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1311272B1 (de) | 2000-03-03 | 2006-11-22 | Eisai Co., Ltd. | Neue methoden unter verwendung von cholinesteraseinhibitoren |
| US20060183776A9 (en) * | 2000-03-03 | 2006-08-17 | Eisai Co., Ltd. | Liquid dosage formulations of donepezil |
| MXPA02010410A (es) * | 2000-04-21 | 2003-04-25 | Upjohn Co | Tratamiento de los sindromes de fibromialgia y de fatiga cronica. |
| WO2002083141A1 (en) * | 2001-04-17 | 2002-10-24 | Pharmacia & Upjohn Company | Treatment of fibromyalgia and chronic fatigue syndrome |
| AT500143A1 (de) * | 2004-04-22 | 2005-11-15 | Sanochemia Pharmazeutika Ag | Cholinesterase-inhibitoren in liposomen sowie deren herstellung und verwendung |
| WO2006081332A1 (en) * | 2005-01-25 | 2006-08-03 | Epix Delaware, Inc. | Substituted arylamine compounds and their use as 5-ht6 modulators |
| CA2597566A1 (en) * | 2005-02-11 | 2006-08-17 | Stephen Wills | Treating microvasculature diseases with acetyl cholinesterase inhibitors |
| US20060270709A1 (en) * | 2005-04-04 | 2006-11-30 | Eisai Co. Ltd. | Dihydropyridine compounds and compositions for headaches |
| WO2008006286A1 (fr) | 2006-07-05 | 2008-01-17 | Tianjin Hemay Bio-Tech Co. Ltd | Dérivés analgésiques 5,9 - méthanocyclo-octa (b) pyridine - 2 (1h) - one, leur procédé de préparation et leur utilisation |
| US8012994B1 (en) | 2006-09-22 | 2011-09-06 | Sevastyanov Victor V | Method for the treatment of sensorineural hearing loss with donepezil hydrochloride (ARICEPT®) |
| EP2089383B1 (de) | 2006-11-09 | 2015-09-16 | Probiodrug AG | 3-hydroxy-1,5-dihydropyrrol-2-one derivate als inhibitoren von glutaminylcyclase zur behandlung von geschwüren, krebs und anderen krankheiten |
| US9126987B2 (en) | 2006-11-30 | 2015-09-08 | Probiodrug Ag | Inhibitors of glutaminyl cyclase |
| AU2008220785B2 (en) | 2007-03-01 | 2013-02-21 | Vivoryon Therapeutics N.V. | New use of glutaminyl cyclase inhibitors |
| JP5667440B2 (ja) | 2007-04-18 | 2015-02-12 | プロビオドルグ エージー | グルタミニルシクラーゼ阻害剤としてのチオ尿素誘導体 |
| US8138169B2 (en) | 2008-04-11 | 2012-03-20 | Comgenrx, Inc. | Combination therapy for bipolar disorder |
| JP5934645B2 (ja) | 2009-09-11 | 2016-06-15 | プロビオドルグ エージー | グルタミニルシクラーゼ阻害剤としてのヘテロ環式誘導体 |
| EA202092673A3 (ru) | 2010-02-09 | 2021-05-31 | Дзе Джонс Хопкинс Юниверсити | Способы и композиции для улучшения когнитивной функции |
| WO2011107530A2 (en) | 2010-03-03 | 2011-09-09 | Probiodrug Ag | Novel inhibitors |
| JP5688745B2 (ja) | 2010-03-10 | 2015-03-25 | プロビオドルグ エージー | グルタミニルシクラーゼ（ｑｃ、ｅｃ２．３．２．５）の複素環阻害剤 |
| WO2011131748A2 (en) | 2010-04-21 | 2011-10-27 | Probiodrug Ag | Novel inhibitors |
| WO2011151359A1 (en) | 2010-06-02 | 2011-12-08 | Noscira, S.A. | Combined treatment with a cholinesterase inhibitor and a thiadiazolidinedione derivative |
| EP2686313B1 (de) | 2011-03-16 | 2016-02-03 | Probiodrug AG | Benzimidazolderivate als glutaminylcyclase-hemmer |
| JP2015078129A (ja) * | 2012-02-01 | 2015-04-23 | 株式会社新日本科学 | ドネペジルを含む線維筋痛症の治療剤 |
| US20140206667A1 (en) | 2012-11-14 | 2014-07-24 | Michela Gallagher | Methods and compositions for treating schizophrenia |
| WO2014144663A1 (en) | 2013-03-15 | 2014-09-18 | The Johns Hopkins University | Methods and compositions for improving cognitive function |
| AU2014228512A1 (en) | 2013-03-15 | 2015-10-01 | Agenebio, Inc. | Methods and compositions for improving cognitive function |
| CA2986598C (en) | 2015-05-22 | 2023-09-26 | Agenebio, Inc. | Extended release pharmaceutical compositions of levetiracetam |
| ES2812698T3 (es) | 2017-09-29 | 2021-03-18 | Probiodrug Ag | Inhibidores de glutaminil ciclasa |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5010083A (en) | 1988-03-28 | 1991-04-23 | Hoechst-Roussel Pharmaceuticals, Inc. | 2,6-methano-1,3-benzodiazocine compounds which have useful pharmaceutical utility |
| DE3927049A1 (de) | 1989-08-16 | 1991-02-21 | Sandoz Ag | Halogenalkyl-phenyl-ketone und deren hydrate, ihre herstellung und verwendung |
| US5336675A (en) * | 1991-05-14 | 1994-08-09 | Ernir Snorrason | Method of treating mania in humans |
| GB9606736D0 (en) * | 1996-02-19 | 1996-06-05 | Shire International Licensing | Therapeutic method |
| AU8742198A (en) | 1997-08-15 | 1999-03-08 | Shire International Licensing B.V. | Use of cholinesterase inhibitor for treating diseases associated with pro teolytic enzyme activity |
-
1998
- 1998-09-11 IT IT1998FI000208A patent/IT1304904B1/it active
-
1999
- 1999-09-09 US US09/763,751 patent/US6608088B1/en not_active Expired - Fee Related
- 1999-09-09 EP EP99946150A patent/EP1112067B1/de not_active Expired - Lifetime
- 1999-09-09 AT AT99946150T patent/ATE327740T1/de active
- 1999-09-09 DK DK99946150T patent/DK1112067T3/da active
- 1999-09-09 WO PCT/EP1999/006648 patent/WO2000015205A2/en not_active Ceased
- 1999-09-09 ES ES99946150T patent/ES2265691T3/es not_active Expired - Lifetime
- 1999-09-09 JP JP2000569789A patent/JP3984787B2/ja not_active Expired - Fee Related
- 1999-09-09 DE DE69931640T patent/DE69931640T2/de not_active Expired - Lifetime
- 1999-09-09 AU AU58617/99A patent/AU5861799A/en not_active Abandoned
- 1999-09-09 PT PT99946150T patent/PT1112067E/pt unknown
-
2006
- 2006-08-07 CY CY20061101098T patent/CY1105125T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DE69931640T2 (de) | 2007-03-08 |
| CY1105125T1 (el) | 2009-11-04 |
| ITFI980208A0 (it) | 1998-09-11 |
| EP1112067A2 (de) | 2001-07-04 |
| DE69931640D1 (de) | 2006-07-06 |
| ITFI980208A1 (it) | 2000-03-11 |
| JP2002524498A (ja) | 2002-08-06 |
| AU5861799A (en) | 2000-04-03 |
| WO2000015205A2 (en) | 2000-03-23 |
| ATE327740T1 (de) | 2006-06-15 |
| PT1112067E (pt) | 2006-09-29 |
| IT1304904B1 (it) | 2001-04-05 |
| ES2265691T3 (es) | 2007-02-16 |
| JP3984787B2 (ja) | 2007-10-03 |
| EP1112067B1 (de) | 2006-05-31 |
| WO2000015205A3 (en) | 2000-08-24 |
| US6608088B1 (en) | 2003-08-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1112067T3 (da) | Anvendelse af acetylcholinesteraseinhibitorer til fremstilling af farmaceutiske præparater til behandling af funktionelle og/eller organiske smertesyndromer | |
| DK0760848T3 (da) | Lactobacillusstammer af menneskelig oprindelse, deres sammensætninger og anvendelse deraf | |
| YU7797A (sh) | Kombinovana terapija za osteoporozu | |
| NO962187D0 (no) | Sammensetninger som inhiberer apoptose, fremgangsmåter for rensing av sammensetningene og anvendelse derav | |
| MY129189A (en) | Prostaglandin agonists and their use to treat bone disorders | |
| DK1039912T3 (da) | Angiostatiske midler og præparater til behandling af GLC1A-glaukom | |
| DK1097173T3 (da) | Anvendelse af peptider af IL-2 og derivater deraf som terapeutiske midler | |
| MY141384A (en) | Prevention of loss and restoration of bone mass by certain prostaglandin agonists | |
| IS5764A (is) | Samsetning til að fyrirbyggja og/eða meðhöndla beingisnun og breytingar vegna tíðahvarfa heilkenna | |
| HUP9700603A1 (hu) | Gyógyászati készítmény véralvadási zavarok kezelésére | |
| DK0951473T3 (da) | Cyclosporinderivat, fremstilling af dette og farmaceutiske præparater indeholdende dette | |
| TR199701669A1 (xx) | Deri preparasyonu i�in bile�imler. | |
| NO985981L (no) | Insulinpreparater som inneholder NaCl | |
| AP9801269A0 (en) | Prostaglandin agonists. | |
| BR9708114A (pt) | Análogos xantona para o tratamento de doenças infecciosas. | |
| PT1109571E (pt) | Metodos de tratamento da hipertensao e composicoes para utilizacao nesses metodos | |
| DK1073456T3 (da) | Anvendelse af osteoprotegerin til forebyggelse og behandling af kardiovaskulære sygdomme | |
| NO983530D0 (no) | Dihydrobenzofuran og relaterte forbindelser anvendelig som anti-inflammatoriske midler | |
| NO964238D0 (no) | Halofantrin-fri-base for behandling av malaria og blandinger | |
| DE60112742D1 (de) | Verwendung von pyrazolderivaten zur behandlung von unfruchtbarkeit | |
| DK0988040T3 (da) | Anvendelse af glucosamin og glucasamin-derivater til hurtig lindring af klöe eller lokaliseret smerte | |
| PT1107793E (pt) | Conjugados de dextrano-leptina, composicoes farmaceuticas e processos relacionados | |
| NO983177L (no) | Anvendelse av 1-enantiomeren av centkroman til fremstilling av et farmasaytisk preparat for behandling eller profylakse av brystkreft | |
| ATE290857T1 (de) | Bretyliumhaltige zusammensetzungen und kits und deren verwendung zur vorbeugung und behandlung cardiovaskulärer erkrankungen | |
| DK1021519T3 (da) | Fremgangsmåde til rengøring af kirurgiske instrumenter |